Omron (OTCMKTS:OMRNY) Cut to “Strong Sell” at Zacks Research

Omron (OTCMKTS:OMRNY) was downgraded by equities researchers at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued to investors on Thursday,Zacks.com reports.

Omron Stock Down 3.5%

Shares of OTCMKTS OMRNY opened at $34.52 on Thursday. The firm has a market cap of $6.79 billion, a price-to-earnings ratio of 36.34, a PEG ratio of 0.44 and a beta of 1.15. The company has a quick ratio of 1.37, a current ratio of 2.11 and a debt-to-equity ratio of 0.13. Omron has a 52-week low of $23.23 and a 52-week high of $40.76. The business’s 50 day moving average is $34.18 and its two-hundred day moving average is $29.93.

Institutional Trading of Omron

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC raised its position in Omron Corp. (OTCMKTS:OMRNY) by 50.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,129 shares of the company’s stock after purchasing an additional 716 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $54,000 as of its most recent SEC filing. 1.09% of the stock is owned by hedge funds and other institutional investors.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.